Changes / RenewalRSSAbout RSS
- January 23, 2020 Release JT Receives Manufacturing and Marketing Approval of CORECTIM® Ointment 0.5% for the Treatment of Atopic Dermatitis in Japan（PDF）
- January 15, 2020 Release Torii Signs Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan（PDF）
- November 29, 2019 Release JT Files New Drug Application of Enarodustat (JTZ-951), for the Treatment of Anemia Associated with CKD in Japan（PDF）
- November 25, 2019 Release Transfer of rights to uricosuric agent URINORM®（PDF）
- November 5, 2019 Release Torii has entered into a License Agreement with BioCryst Pharmaceuticals, Inc. for BCX7353 for the prevention of HAE attacks（PDF）